Budesonide/Formoterol Turbuhaler

DRUG9 trials

Sponsors

AstraZeneca

Conditions

AsthmaCOPD Method EvaluationChronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease Method Evaluation

Early Phase 1

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

CompletedNCT01257048

AstraZenecaChronic Obstructive Pulmonary Disease Method Evaluation, COPD Method Evaluation

Start: 2011-08-31End: 2012-06-30Updated: 2012-09-03

Phase 3

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

CompletedNCT00235911

AstraZenecaAsthma

Start: 2003-09-30End: 2006-12-31Target: 100Updated: 2011-01-24

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

CompletedNCT00238784

AstraZenecaAsthma

Start: 2004-05-31End: 2005-10-31Target: 1300Updated: 2008-01-14

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

CompletedNCT00242775

AstraZenecaAsthma

Start: 2005-05-31End: 2006-05-31Target: 2100Updated: 2011-01-24

A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®

CompletedNCT00244608

AstraZenecaAsthma

Start: 2005-05-31End: 2007-03-31Target: 100Updated: 2011-01-24

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

CompletedNCT00259792

AstraZenecaAsthma

Start: 2004-09-30End: 2006-01-31Target: 1000Updated: 2011-01-24

Phase 4

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults

CompletedNCT00242411

AstraZenecaAsthma

Start: 2004-09-30End: 2006-10-31Target: 1900Updated: 2011-01-24

Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations

CompletedNCT00272753

AstraZenecaAsthma

Start: 2004-04-30End: 2005-11-30Target: 20Updated: 2011-06-01

Airway Clearance Study

CompletedNCT00379028

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2006-09-30End: 2007-07-31Updated: 2011-01-24

Related Papers

Direct healthcare cost comparison of Fluticasone propionate/Salmeterol vs Budesonide/Formoterol Maintenance And Reliever Therapy for moderate/severe asthma: Results from Thailand.

2025-03-01

Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.

2021-03-274 citations

The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.

2009-10-3160 citations